206 related articles for article (PubMed ID: 30850359)
1. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Clin Cancer Res; 2019 Jun; 25(12):3702-3717. PubMed ID: 30850359
[TBL] [Abstract][Full Text] [Related]
2. CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway.
Chang TM; Chiang YC; Lee CW; Lin CM; Fang ML; Chi MC; Liu JF; Kou YR
Int J Biol Sci; 2023; 19(5):1455-1470. PubMed ID: 37056937
[No Abstract] [Full Text] [Related]
3. A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?
Zhang Q; Zhou N; Wang W; Zhou S
Clin Cancer Res; 2019 Jun; 25(12):3476-3478. PubMed ID: 30952637
[TBL] [Abstract][Full Text] [Related]
4. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
[TBL] [Abstract][Full Text] [Related]
6. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Augsten M; Hägglöf C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3414-9. PubMed ID: 19218429
[TBL] [Abstract][Full Text] [Related]
7. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
[TBL] [Abstract][Full Text] [Related]
8. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
9. CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.
Ji X; Shen Z; Zhao B; Yuan X; Zhu X
Medicine (Baltimore); 2018 Mar; 97(10):e0101. PubMed ID: 29517684
[TBL] [Abstract][Full Text] [Related]
10. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
11. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
[TBL] [Abstract][Full Text] [Related]
13. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
14. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
15. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.
McKinnon CM; Lygoe KA; Skelton L; Mitter R; Mellor H
Oncogene; 2008 Nov; 27(54):6856-65. PubMed ID: 18762809
[TBL] [Abstract][Full Text] [Related]
16. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C
J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544
[TBL] [Abstract][Full Text] [Related]
17. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
19. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.
Kleer CG; Bloushtain-Qimron N; Chen YH; Carrasco D; Hu M; Yao J; Kraeft SK; Collins LC; Sabel MS; Argani P; Gelman R; Schnitt SJ; Krop IE; Polyak K
Clin Cancer Res; 2008 Sep; 14(17):5357-67. PubMed ID: 18765527
[TBL] [Abstract][Full Text] [Related]
20. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
